Cryoport Inc. is a global life sciences logistics and services company focused on temperature-controlled supply chain solutions for biologic materials. Cryoport Inc. supports the movement, storage, handling, and monitoring of sensitive products used in cell and gene therapy, biopharmaceuticals, animal health, and reproductive medicine. Its current offerings include specialized bio-logistics, bio-storage, bio-processing, cryopreservation, and cryogenic equipment, along with related software and monitoring tools designed to help maintain product integrity throughout transit and storage. Through its Life Sciences Services and Life Sciences Products segments, Cryoport Inc. serves biotechnology and pharmaceutical companies, contract research organizations, fertility clinics, and other healthcare-focused customers worldwide. Headquartered in Brentwood, Tennessee, Cryoport Inc. plays an important role in the infrastructure that supports advanced therapies and other temperature-sensitive life sciences applications.
Website112 Westwood Place
Brentwood, TN, 37027
United States
The latest analyst work on Cryoport points to a higher blended fair value estimate, with price targets moving from US$17.06 to US$19.33, about a 13% uplift in the modeled target level. That shift lines up with more constructive Street commentary, as several bullish analysts highlight Cryoport’s Cell and Gene Therapy logistics and bioservices as key supports for the higher target range. As you read on, you will see how to track these shifting assumptions and what they might mean for your own...
Detailed price information for Cryoport Inc (CYRX-Q) from The Globe and Mail including charting and trades.
CGT services revenue surged 15% as clinical trial support expanded to 779 trials globally.
CryoPort (CYRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Investors talking about CYRX also mention
What share of all stock conversation is about CYRX?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% 0 | 0% 0 | 0% 0 | 0% +0 |
Of the messages about CYRX that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | — | — | — | 99.11% +5.71 | ||
| Bearish | — | — | — | 0.89% -5.71 |
Of the messages about CYRX that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Announcements | — | — | — | 78.11% | ||
| Analysts | — | — | — | 3.13% | ||
| Controversies | — | — | — | 0% | ||
| Earnings | — | — | — | 2.26% | ||
| Macro | — | — | — | 0% | ||
| Technical Analysis | — | — | — | 16.51% |
Of the messages about CYRX, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | — | — | 3.33% | 5.53% | ||
| Newcomers | — | — | 96.67% | 94.47% |